Achievement of Tolerance Induction to Prevent Acute Graft-vs.-Host Disease

Acute graft-vs.-host disease (GVHD) limits the efficacy of allogeneic hematopoietic stem cell transplantation (allo-HSCT), a main therapy to treat various hematological disorders. Despite rapid progress in understanding GVHD pathogenesis, broad immunosuppressive agents are most often used to prevent...

Descripción completa

Detalles Bibliográficos
Autores principales: Thangavelu, Govindarajan, Blazar, Bruce R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419712/
https://www.ncbi.nlm.nih.gov/pubmed/30906290
http://dx.doi.org/10.3389/fimmu.2019.00309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419712/
https://www.ncbi.nlm.nih.gov/pubmed/30906290
http://dx.doi.org/10.3389/fimmu.2019.00309

Ejemplares similares